ANNEX 8. Guideline Development group, Guideline Steering Group, Systematicreview teams, External Review Group GUIDELINES DEVELOPMENT GROUP Jacinto Amandua Ministry of Health Uganda Isabelle Andrieux-Meyer Médecins Sans Frontières Manal Hamdy El-Sayed Egypt National Hepatitis Committee Egypt Charles Gore World Hepatitis Alliance Margaret Hellard (Chair) Centre for Population Health Burnet Institute Melbourne, Australia Niklas Luhmann Médecins du Monde Paris, France Michael Ninburg Hepatitis Education Project Seattle, USA Richard Njouom Centre Pasteur of Cameroon Cameroon, Africa John Parry Public Health England Trevor Peter Clinton Health Access Initiative New York, USA Teri Roberts Giten Khwairakpam Singh TREAT Asia/amFAR Bangkok, Thailand Lara Tavoschi European Center for Disease Prevention and Control Stockholm, Sweden Richard Tedder (Unable to attend) Public Health England Roger Chou Oregon Health & Science University Portland, USA Methodologist Page 632
GUIDELINES STEERING COMMITTEE GROUP Rachel Baggaley Coordinator, HIV Key Populations and Innovative Prevention Nicolas Campion Clark Medical Officer, HQ/MSB Management of Substance Shaffiq Essajee Medical Officer, Treatment and Care, HIV/AIDS Cheryl Johnson Consultant, HIV Key Populations and Innovative Prevention Anita Sands Technical Officer, Essential Medicines & Health Products Willy Urassa Essential Medicines & Health Products Marco Vitoria Medical Officer, Treatment and Care, HIV/AIDS Junping YU Technical officer Blood & Transfusion Safety (BTS) Service Delivery and Safety (SDS) Page 633
SYSTEMATIC REVIEW TEAMS Rosanna Peeling London School of Hygiene and Tropical Medicine Claudia Denkinger Jennifer Cohn Médecins Sans Frontières Timothy Hallet Benjamin P Linas Kali Zhou University of California, Department of Medicine San Francisco, USA Thomas Fitzpatrick University of Washington, School of Medicine Seattle, USA Nick Walsh Roger Chou Oregon Health & Science University Portland, USA Methodologist Jake Morgan Shevanthi Nayagam Berit Lange Center for Chronic Immunodeficiency & Division for Infectious Diseases, Medical Department II, University Hospital Freiburg, Germany Ali Amini Helen Kelly Debra Boeras Wen Chen, Jane Falconer Weiming Tang Olivia Varsaneux Teri Roberts Edouard Tuaillon Page 634
Montpellier Teaching Hospital Montpellier, France Joseph Tucker UNC Project -China University of North Carolina, USA Philippe Van de Perre Université Montpellier EFS & CHU Montpellier, France Mellanye Lackey Ji Young Kim University of Utah Salt Lake City, USA Timothy Hallet Shevanthi Nayagam Julia Scott Page 635
MODELLING TEAM Benjamin P Linas Jake Morgan John Parry Public Health England VALUES AND PREFERENCES SURVEY Elena Ivanova Alessandra Trianni Teri Roberts FEASIBILITY SURVEY Niklas Luhmann Médecins du Monde Paris, France Julie Bouscaillou Médecins du Monde Paris, France Azumi Ishizaki WHO headquarters Page 636
EXTERNAL PEER REVIEW GROUP Jilian Sacks Clinton Health Access Initiative USA Tanya Applegate Kirby Institute Australia Cami Graham Beth Israel Deaconess Medical Center USA Gilles Wandeler University of Bern Switzerland Mark Sonderup University of Cape Town South Africa Ponsiano Ocama Makerere University Uganda Stephen Locarnini Doherty Institute Australia Alaa Gad Hashish Al Shams University Egypt Jean-Bosco Ndinokubwayo WHO Regional Office for Africa Nick Walsh Yap Boum Epicentre, Medecin sans Frontiere France Susan Best National Serology Reference Laboratory Australia Joumana Hermez WHO, Egypt Jules Mugabo Semahore WHO, Rwanda Yvan Hutin WHO Headquarters Hande Harmanci WHO Headquarters Stefan Wiktor WHO Headquarters Page 637